HCA Healthcare to Report Q2 Earnings: Key Estimates to Note

HCA Healthcare is set to report Q2 2025 earnings on July 25, with consensus estimates forecasting EPS of $6.14 (+11.6% YoY) on revenues of $18.46 billion (+5.5% YoY). Despite projected increases in admissions, patient days, and occupancy, rising operating expenses and an anticipated decline in outpatient surgeries are expected to pressure results. While HCA has a strong history of beating earnings estimates, Zacks' model does not conclusively predict an earnings beat for this quarter, primarily due to a negative Earnings ESP.

Analysis

HCA Healthcare is approaching its second-quarter 2025 earnings report with consensus estimates projecting significant top and bottom-line growth. Forecasts anticipate an 11.6% year-over-year increase in EPS to $6.14 and a 5.5% rise in revenues to $18.46 billion. This growth is underpinned by solid operational metrics, including expected increases in equivalent admissions (+2.9%), equivalent patient days (+4.3%), and facility occupancy (to 73.1% from 71.9%). However, these positive demand signals are contrasted by considerable headwinds. Total operating expenses are projected to increase by 6.5%, outpacing revenue growth and suggesting potential margin compression driven by higher salaries and a 5.3% jump in supply costs. Furthermore, a 2.2% year-over-year decline is anticipated in outpatient surgery cases, indicating a soft spot in a key service line. While HCA has a strong track record of beating earnings estimates over the last four quarters, the current Zacks model does not forecast a beat, citing a negative Earnings ESP of -8.77%, which introduces a notable element of uncertainty for the upcoming report.

Key Decisions for Investors

• Investors should weigh the strong projected revenue growth against the significant risk of margin compression, as operating expenses are forecast to rise 6.5%, faster than the expected 5.5% revenue increase.
• Given the negative Earnings ESP of -8.77% and the model's prediction of no beat, investors banking on a positive earnings surprise should exercise caution, as the company's strong history of beats may not repeat this quarter.
• Monitor the earnings release for commentary on cost containment strategies and the outlook for outpatient surgery volumes, as these are the primary identified headwinds that could impact future profitability.
• For those seeking near-term earnings catalysts within the healthcare provider space, it may be prudent to evaluate the relative strength of peers like Tenet Healthcare (THC) and Cencora (COR), which are cited as having a higher probability of an earnings beat based on their positive Earnings ESP.